CN Patent

CN101293908B — 用于端粒酶抑制的改性寡核苷酸

Assigned to Geron Corp · Expires 2015-05-06 · 11y expired

What this patent protects

本发明公开了包括共价共轭脂质部分的寡核苷酸部分的化合物。寡核苷酸部分包括与人端粒酶的RNA成分互补的序列。该化合物高效抑制细胞中的端粒酶活性并具有优良的细胞吸收特性。

USPTO Abstract

本发明公开了包括共价共轭脂质部分的寡核苷酸部分的化合物。寡核苷酸部分包括与人端粒酶的RNA成分互补的序列。该化合物高效抑制细胞中的端粒酶活性并具有优良的细胞吸收特性。

Drugs covered by this patent

imetelstat-sodium (IMETELSTAT SODIUM)

Patent Metadata

Patent number: CN101293908B
Jurisdiction: CN
Classification: —
Expires: 2015-05-06
Drug substance claim: No
Drug product claim: No
Assignee: Geron Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.